Meroterpenoids Produced by Fungi: Occurrence, Structural Diversity, and Biological Activity (An Update: February 2020 to December 2025)
Chemistry & Biodiversity · 2026-11 · 23 (11)
DOI: 10.1002/cbdv.71889 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, online erschienen am 30.10.2026. Verfasst von Yuqian Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chinese Medicinal Resource from Lingnan, Key Laboratory of Chronic Disease Prevention and Control of Traditional Chinese Medicine o…. Hauptthemen laut MEDLINE: Terpenes, Fungi, Biological Products, Antineoplastic Agents. Die Arbeit nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Special Project for Marine Economic Development of the Department of Natural Resources of Guangdong Province, open foundation of the Key Laboratory of Tropical Medicinal Resource Chemistry of the Ministry of Education.
Abstract (Originalsprache)
Meroterpenoids are a class of hybrid natural products, biosynthesized from terpenoid fragments and non‐terpenoid precursors, exhibiting a wide range of biological activities, that provide an important source of compounds for new drug development. This review firstly summarizes the update of meroterpenoids from February 2020 to December 2025 by applying a new classification method based on twelve key non‐terpene precursors. A total of 906 new meroterpenoids were reported from 214 studies, while recent synthetic and biosynthetic investigations have further expanded both the accessible chemical space and our mechanistic understanding of this compound class. Among them, biosynthetic pathways originating from 4‐hydroxybenzoic acid and 3,5‐dimethylorsellinic acid were found to be the highest proportion. Statistical analysis shows that over 40% of the cataloged compounds exhibit broad biological activities, with anti‐cancer, anti‐inflammatory, and antimicrobial effects being the top three. The significant structural variety and potent bioactivity of fungal meroterpenoids serve as a sustainable source for novel drug lead compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Chinese Medicinal Resource from Lingnan, Key Laboratory of Chronic Disease Prevention and Control of Traditional Chinese Medicine of Guangdong Higher Education Institutes, Ministry of Education, School…
ORCID-Profile: Yuqian Tang, Yingming Luo, Yan Zhou, Jiafan Yang, Hui Cui
Förderung
- National Natural Science Foundation of China
- Special Project for Marine Economic Development of the Department of Natural Resources of Guangdong Province
- open foundation of the Key Laboratory of Tropical Medicinal Resource Chemistry of the Ministry of Education
Zitieren
APA
Tang, Y., Wei, J., Jiang, Z., Luo, Y., Zhou, Y., Yang, J., & Cui, H. (2026). Meroterpenoids Produced by Fungi: Occurrence, Structural Diversity, and Biological Activity (An Update: February 2020 to December 2025). Chemistry & Biodiversity, 23(11). https://doi.org/10.1002/cbdv.71889
Vancouver
Tang Y, Wei J, Jiang Z, Luo Y, Zhou Y, Yang J, et al. Meroterpenoids Produced by Fungi: Occurrence, Structural Diversity, and Biological Activity (An Update: February 2020 to December 2025). Chemistry & Biodiversity. 2026;23(11). doi:10.1002/cbdv.71889
BibTeX
@article{Tang2026,
author = {Tang, Yuqian and Wei, Jinqin and Jiang, Zhao and Luo, Yingming and Zhou, Yan and Yang, Jiafan and Cui, Hui},
title = {Meroterpenoids Produced by Fungi: Occurrence, Structural Diversity, and Biological Activity (An Update: February 2020 to December 2025)},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {11},
doi = {10.1002/cbdv.71889}
}
EUVIMED